SCHEMBL27101050

SCHEMBL27101050

Cc1cnc(NC2CCN(C(=O)OC(C)(C)C)CC2)c(N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
BTK Q06187 1/20 0.49
MAPT P10636 2/20 0.49
NPC1 O15118 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GPR119 Q8TDV5 4/20 0.48
NSD2 O96028 1/20 0.48
SYK P43405 1/20 0.46
PIK3CD O00329 1/20 0.46
CNR1 P21554 2/20 0.46
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
EPHX2 P34913 1/20 0.45
EPHX1 P07099 1/20 0.44
JAK1 P23458 1/20 0.44
CNR2 P34972 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29712740 1.00 ALDH1A1 (0.50) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL29124358 0.94 PIK3CD (0.53) ALDH1A1BTKGPR119PIK3CD
SCHEMBL31170908 0.94 PIK3CD (0.53) ALDH1A1BTKGPR119PIK3CD
SCHEMBL29124357 0.94 PIK3CD (0.53) ALDH1A1BTKGPR119PIK3CD
SCHEMBL20135051 0.89 ALDH1A1 (0.52) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL29417829 0.88 ALDH1A1 (0.49) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL27101037 0.88 ALDH1A1 (0.51) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL27101047 0.86 ALDH1A1 (0.50) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL26671813 0.83 GPR119 (0.48) ALDH1A1BTKMAPTNPC1MAPK1
SCHEMBL20135033 0.82 PIK3CD (0.52) ALDH1A1BTKPIK3CDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF LG CHEM, LTD. (KR) 2024-02-29 US disclosed
CN-116615199-A Heterocyclic compounds as diacylglycerol kinase inhibitors and uses thereof 株式会社LG化学 2023-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067645-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF DGKA, DGKB, DGKK ALDH1A1 2241/4885BTK 455/4885MAPT 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.